Acute esophageal necrosis (AEN) is an uncommon endoscopic finding characterized by a patchy or diffuse circumferential black pigmentation of the esophageal mucosa, corresponding to ischemic necrosis. It usually presents with upper gastrointestinal bleeding and is thought to be caused by a systemic low blood flow in patients with predisposing risk factors, like advanced age and cardiovascular comorbidities. After initial hemodynamic stabilization, diagnosis is established by esophagogastroduodenoscopy (EGD) with careful biopsies and histological evaluation. Delayed diagnosis is thought to be the main cause of panesophageal necrosis, perforation, mediastinitis and septic shock. We present a case of AEN triggered by hypoperfusion due to severe perioperative blood loss in a 72-year-old woman with a history of cardiovascular disease. Even though she was stabilized during surgery, she still presented with melena 24 hours after, and endoscopic examination showed ischemic patches consistent with AEN. After administering intravenous fluids, proton pump inhibitors (PPI) and parenteral nutrition, a repeat EGD after 72 hours showed a neat improvement with erosive and ulcerative lesions replacing the black patches and a complete healing after eight weeks of oral PPI therapy. AEN is a rare but highly deadly entity that endoscopists must be aware of, especially in patients with multiple comorbidities and presenting with gastrointestinal bleeding after an episode of hemodynamic instability. Quick management can significantly improve survival.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11733398PMC
http://dx.doi.org/10.7759/cureus.75769DOI Listing

Publication Analysis

Top Keywords

gastrointestinal bleeding
8
black esophagus
4
esophagus life-threatening
4
life-threatening consequence
4
consequence hypoperfusion
4
hypoperfusion acute
4
acute esophageal
4
esophageal necrosis
4
aen
4
necrosis aen
4

Similar Publications

Background: The non-vitamin K oral anticoagulant (NOAC), edoxaban, is approved for stroke prevention in patients with atrial fibrillation (AF) in many Asian countries. Nonetheless, data on its long-term effectiveness and safety in routine clinical practice are limited in Taiwan.

Methods: The Global ETNA-AF (Edoxaban Treatment in routiNe clinical prActice) registry is an observational study that integrates data of AF patients receiving edoxaban from multiple regional registries.

View Article and Find Full Text PDF

Introduction: Gastrointestinal bleeding (GIB) is often encountered among patients with atrial fibrillation (AF) due to the use of anticoagulation. This study assesses disparities in GIB-related mortality among decedents with AF in the United States.

Methods: GIB mortality data in patients with AF from 1999 to 2020 was queried from the CDC database.

View Article and Find Full Text PDF

Background: Cancer is a major public health challenge in West Africa, with a significant proportion of cancer-related deaths attributed to distant metastasis. De novo metastatic cancer (DnMC), where metastasis is detected at diagnosis, presents considerable therapeutic challenges, particularly in limited-resource settings where novel treatments are often unavailable and/or unaffordable.

Aim: To determine the prevalence, incidence and clinicopathological characteristics of patients diagnosed with DnMC at a major radiotherapy center in West Africa.

View Article and Find Full Text PDF

Acute esophageal necrosis (AEN) is an uncommon endoscopic finding characterized by a patchy or diffuse circumferential black pigmentation of the esophageal mucosa, corresponding to ischemic necrosis. It usually presents with upper gastrointestinal bleeding and is thought to be caused by a systemic low blood flow in patients with predisposing risk factors, like advanced age and cardiovascular comorbidities. After initial hemodynamic stabilization, diagnosis is established by esophagogastroduodenoscopy (EGD) with careful biopsies and histological evaluation.

View Article and Find Full Text PDF

International guidelines recommend early enteral nutrition (EEN) for critically ill patients. However, evidence supporting the optimal timing of EN in patients diagnosed with cardiogenic shock (CS) is lacking. As such, this study aimed to compare the clinical outcomes and safety of EEN versus delayed EN in patients diagnosed with CS.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!